Jane Street Group, LLC Curis Inc Transaction History

Jane Street Group, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$0.51 - $0.78 $121,187 - $185,345	-237,623 Reduced 89.28%	28,542 $17,000
Q4 2022 Feb 14, 2023	BUY	$0.47 - $17.22 $106,077 - $3.89 Million	225,696 Added 557.7%	266,165 $146,000
Q3 2022 Nov 14, 2022	SELL	$0.74 - $15.01 $30,394 - $616,520	-41,074 Reduced 50.37%	40,469 $28,000
Q2 2022 Aug 16, 2022	SELL	$0.71 - $2.43 $56,812 - $194,443	-80,018 Reduced 49.53%	81,543 $80,000
Q1 2022 May 17, 2022	SELL	$2.31 - $5.13 $236,266 - $524,696	-102,280 Reduced 38.77%	161,561 $385,000
Q4 2021 Feb 15, 2022	BUY	$4.45 - $8.09 $986,698 - $1.79 Million	221,730 Added 526.54%	263,841 $1.26 Million
Q3 2021 Nov 16, 2021	SELL	$6.94 - $8.85 $1.59 Million - $2.03 Million	-228,858 Reduced 84.46%	42,111 $329,000
Q2 2021 Aug 16, 2021	BUY	$7.45 - $16.27 $1.05 Million - $2.28 Million	140,350 Added 107.45%	270,969 $2.19 Million
Q1 2021 May 18, 2021	BUY	$8.78 - $12.8 $607,224 - $885,248	69,160 Added 112.53%	130,619 $1.48 Million
Q4 2020 Feb 17, 2021	BUY	$1.08 - $8.2 $14,126 - $107,255	13,080 Added 27.04%	61,459 $503,000
Q3 2020 Nov 17, 2020	BUY	$0.95 - $1.42 $45,960 - $68,698	48,379 New	48,379 $57,000
Q3 2018 Nov 14, 2018	SELL	$1.38 - $1.94 $39,779 - $55,922	-28,826 Closed	0 $0
Q2 2018 Aug 15, 2018	BUY	$1.73 - $3.35 $49,868 - $96,567	28,826 New	28,826 $50,000

Ticker CRIS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 91,814,704
Market Cap $393M
Description
Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small molecule drug candidate, which is in a Phase 1/2 clinical trial for the treatment of non-hodgkin lymphomas, and acute myel...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.